A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma

NCT00949702 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Melanoma

Interventions

DRUG: vemurafenib

Sponsor

Hoffmann-La Roche